REPROGRAMMING MEDIATED BY CELL FUSION TECHNOLOGY

被引:9
作者
Serov, Oleg L. [1 ]
Matveeva, Natalia M. [1 ]
Khabarova, Anna A. [1 ]
机构
[1] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia
来源
INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 291 | 2011年 / 291卷
关键词
Hybrid cells; Cell fusion; Reprogramming; Heterokaryons; Epigenome; Gene expression; Cell differentiation; EMBRYONIC STEM-CELLS; CELL/FIBROBLAST HYBRID-CELLS; X-CHROMOSOME INACTIVATION; GENE-EXPRESSION; SOMATIC-CELLS; NUCLEAR TRANSFER; TERATOCARCINOMA CELLS; IN-VITRO; NULLIPOTENT TERATOCARCINOMA; CHROMATIN-STRUCTURE;
D O I
10.1016/B978-0-12-386035-4.00005-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review is focused on recent advances in fusion-based reprogramming of cells of different pluripotent statuses or lineage origins. Recent findings are discussed from standpoints of both the developmental potency of hybrid cells generated by fusion of pluripotent embryonic stem (ES) cells, embryonal carcinoma (EC) cells, and somatic cells and epigenetic mechanisms and other aspects involved in the reprogramming process. Complete reprogramming occurs at least 5-7 days after fusion and includes at least two steps. (i) initiation at the heterokaryon stage and choice of the direction of reprogramming using an "all-or-none principle" to establish the dominance of one parental genome and (ii) "fixation" of the newly acquired expression profile by epigenetic mechanisms. The first step is realized without cell division, whereas the second requires cell proliferation. Reprogramming in hybrid cells is rapid and complete. Thus, cell fusion is a powerful tool for reprogramming.
引用
收藏
页码:155 / 190
页数:36
相关论文
共 142 条
  • [1] Allan B., 1987, TERATOCARCINOMA EMBR, P125
  • [2] Reprogramming mediated by stem cell fusion
    Ambrosi, DJ
    Rasmussen, TP
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2005, 9 (02) : 320 - 330
  • [3] Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cells
    Ambrosi, Dominic J.
    Tanasijevic, Borko
    Kaur, Anupinder
    Obergfell, Craig
    O'Neill, Rachel J.
    Krueger, Winfried
    Rasmussen, Theodore P.
    [J]. STEM CELLS, 2007, 25 (05) : 1104 - 1113
  • [4] ANTIGEN EXPRESSION BY SOMATIC-CELL HYBRIDS OF A MURINE EMBRYONAL CARCINOMA CELL WITH THYMOCYTES AND L-CELLS
    ANDREWS, PW
    GOODFELLOW, PN
    [J]. SOMATIC CELL GENETICS, 1980, 6 (02): : 271 - 284
  • [5] [Anonymous], 1994, Manipulating the mouse embryo: a laboratory manual
  • [6] REEXPRESSION OF A T-T-COMPLEX ANTIGEN (T12) IN THYMOCYTEXEMBRYONAL CARCINOMA CELL HYBRIDS
    ARTZT, K
    JACOBSCOHEN, RJ
    DIMEO, A
    ALTON, AK
    DARLINGTON, G
    [J]. SOMATIC CELL GENETICS, 1981, 7 (04): : 423 - 434
  • [7] NULLIPOTENT TERATOCARCINOMA CELLS ACQUIRE THE PLURIPOTENCY FOR DIFFERENTIATION BY FUSION WITH SOMATIC-CELLS
    ATSUMI, T
    SHIRAYOSHI, Y
    TAKEICHI, M
    OKADA, TS
    [J]. DIFFERENTIATION, 1982, 23 (01) : 83 - 86
  • [8] MAINTENANCE OF HEMOGLOBIN INDUCIBILITY IN SOMATIC-CELL HYBRIDS OF TETRAPLOID (2S) MOUSE ERYTHROLEUKEMIA CELLS WITH MOUSE OR HUMAN FIBROBLASTS
    AXELROD, DE
    GOPALAKRISHNAN, TV
    WILLING, M
    ANDERSON, WF
    [J]. SOMATIC CELL GENETICS, 1978, 4 (02): : 157 - 168
  • [9] Battulin N.R., 2011, WORLD J STEM C UNPUB
  • [10] Allelic expression and DNA methylation profiles of promoters at the parental Oct4 and Nanog genes in Mus musculus ES cell/Mus caroli splenocyte hybrid cells
    Battulin, Nariman R.
    Pristyazhnyuk, Inna E.
    Matveeva, Natalia M.
    Fishman, Veniamin S.
    Vasilkova, Anna A.
    Serov, Oleg L.
    [J]. CELL AND TISSUE RESEARCH, 2009, 337 (03) : 439 - 448